News
TARO
42.97
0.00%
0.00
Ademi LLP announces the filing of Class Action Lawsuit against Taro Pharmaceutical Industries Ltd. and other Defendants
PR Newswire · 09/11 01:31
Weekly Report: what happened at TARO last week (0617-0621)?
Weekly Report · 06/24 09:16
Weekly Report: what happened at TARO last week (0610-0614)?
Weekly Report · 06/17 09:15
Weekly Report: what happened at TARO last week (0603-0607)?
Weekly Report · 06/10 09:15
Weekly Report: what happened at TARO last week (0527-0531)?
Weekly Report · 06/03 09:16
Weekly Report: what happened at TARO last week (0520-0524)?
Weekly Report · 05/27 09:16
Taro shareholders approve go-private deal with Sun Pharma
Seeking Alpha · 05/23 12:35
Taro Pharmaceutical Greenlights Merger With Sun Pharma
TipRanks · 05/23 11:59
Taro Pharmaceutical Reports Strong Fiscal Year
TipRanks · 05/21 13:59
TARO Stock Earnings: Taro Pharmaceutical Indus Reported Results for Q4 2024
Investorplace · 05/21 01:53
Taro Pharmaceutical GAAP EPS of $0.40 beats by $0.09, revenue of $164.94M beats by $8.88M
Seeking Alpha · 05/20 21:25
Taro Pharmaceutical Indus Q4 Adj EPS $0.43 Beats $0.31 Estimate, Sales $164.941M Beat $156.062M Estimate
Benzinga · 05/20 21:16
After-Hours Earnings Report for May 20, 2024 : PANW, TCOM, KEYS, ZM, NDSN, TARO, TRNS, TUYA, BEEM, XELB
NASDAQ · 05/20 18:00
Taro: Fiscal Q4 Earnings Snapshot
Barchart · 05/20 16:25
Taro Provides Results for Year Ended March 31, 2024
Barchart · 05/20 16:00
Weekly Report: what happened at TARO last week (0513-0517)?
Weekly Report · 05/20 09:15
Weekly Report: what happened at TARO last week (0506-0510)?
Weekly Report · 05/13 09:16
Weekly Report: what happened at TARO last week (0429-0503)?
Weekly Report · 05/06 09:17
Weekly Report: what happened at TARO last week (0422-0426)?
Weekly Report · 04/29 09:17
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TARO, HES, ANSS
Barchart · 04/23 12:03
More
Webull provides a variety of real-time TARO stock news. You can receive the latest news about Taro Pharmaceutical Inds Ltd through multiple platforms. This information may help you make smarter investment decisions.
About TARO
Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets over 200 pharmaceutical products in over 25 countries. The Company's owned product brands include Rokacet, with generic names, such as acetaminophen, codeine and caffeine; Topicort, with the generic name, desoximetasone; Etopan, with the generic name etodolac, and Ovide, with the generic name, malathion, among others. The Company's other generic products include acetazolamide, adapalene, alclometasone dipropionate, amiodarone hydrochloride, ammonium lactate, augmented betamethasone dipropionate, cetirizine hydrochloride, clobetasol propionate, clomipramine hydrochloride, clorazepate dipotassium, fluorouracil, ketoconazole, metronidazole, mupirocin and warfarin sodium, among others.